Corvus Pharmaceuticals, Inc. Equity Method Investments
Corvus Pharmaceuticals, Inc. (CRVS) had Equity Method Investments of $15.11 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-06
- 2026-06-30: Equity Method Investments $15.11M.
- 2026-03-31: Equity Method Investments $10.50M.
- 2025-12-31: Equity Method Investments $10.99M.
- 2025-09-30: Equity Method Investments $11.53M.
| Period end | Equity Method Investments |
|---|---|
| 2026-06-30 | $15.11M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $10.50M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $10.99M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $11.53M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $11.79M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $12.06M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $12.54M 10-K · filed 2026-03-12 |
| 2024-09-30 | $15.19M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.40M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.07M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $16.12M 10-K · filed 2025-03-25 |
| 2023-09-30 | $17.07M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $18.02M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $20.23M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $21.88M 10-K · filed 2024-03-19 |
| 2022-09-30 | $25.91M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $30.18M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $33.37M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $34.27M 10-K · filed 2023-03-28 |
| 2021-09-30 | $36.33M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $38.05M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $37.13M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $37.23M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |